We are proud to announce International Webinar on Nursing 2020. Offer ends in 2 days. This offer valid for only 2 days. Hurry up and register soon.
Let me know if anyone is interested and remaining people who got your discount links, please register as soon as possible. Standard prices are $249 and $349 for student/delegate and speaker registration respectively. But we are providing discount on registration fee and you can register as a delegate/student for $99 and as a speaker for $149. Let me know if you are interested.
Watch International Webinar on Nursing and Emergency Medicine Live Online
LIVE>>>http://livehdtvonline24.com/International-Webinar-on-Nursing-and-Emergency-Medicine/
LIVE>>>http://livehdtvonline24.com/International-Webinar-on-Nursing-and-Emergency-Medicine/
International Webinar on Nursing and Emergency Medicine Live online, International Webinar on Nursing and Emergency Medicine Live Streaming,
the XXVII European Congress of Perinatal Medicine 2021 is dedicated to topics in the field of perinatal medicine, including, global health issues concerning mothers and infants in the phase of conception, pregnancy and early infancy.
The XXVII European Congress of Perinatal Medicine 2021 covers topics such as:
Developmental origins of health and disease & Periconceptional programming
Qualitative and quantitative maternal, fetal and neonatal nutrition
Perinatal and obstetrical syndromes
Breastfeeding
IUGR
Diabetes in Pregnancy
Early PPROM, Late preterm birth
Preterm labor & delivery, progesterone, antenatal steroids
Maternal chronic disease Delivery room maternal and neonatal emergencies
Preeclampsia
Oxygenation targets; haemodynamics & tissue oxygenation; oxidative stress
Inflammation and lung disease; ductus arteriosus
Quality of care, nosocomial infections
Gut microbiota; prevention of necrotizing enterocolitis
Retinopathy of prematurity Stem cell therapy and cord blood storage
Long term follow-up
The XXVII European Congress of Perinatal Medicine 2021 brings together specialists in the field of perinatal medicine, including midwives, obstetricians and neonatologists as well as professionals who work in fields such as child pathology, paediatric surgery, genetics, prenatal diagnosis and IVF. Also epidemiologists and health care workers.
Unfortunately, the upcoming “International Webinar on Nursing and Emergency Medicine” which has to be held on November 4th, 2020 has been postponed to November 20th, 2020 at the request of many of our speakers.
So if any of you are interested to join as a speaker, please let us know and submit your abstract at https://larixconferences.com/nursing/submitabstract
or email us at [email protected]
While the gender pay gap plays out differently across the health sector, with a 17% pay gap in medicine and no gender pay gap in nursing, women’s progression to the top jobs is problematic across the board. In medicine, women are highly underrepresented within consultant grades, while almost one in five men in the UK nursing workforce are achieving the top jobs in the sector, while women lose out on the top salaried roles. However, little analysis has been undertaken on what factors, besides gender, affect pay in the sector, despite evidence that factors such as race play an important role too.
Join The Equality Trust to explore and discuss the impact of both gender and racial inequalities in stunting career progression and pay equity for women and BAME workers in the healthcare sector, presenting brand new research from the UK’s leading experts.
Guest speakers
Professor Carol Woodhams - Professor of Human Resource Management and Head of Department of People and Organisations, University of Surrey
Ira Parnerkar, Doctoral student, Queen Mary University of London
Rachael McIlroy - Senior Research Lead, Royal College of Nursing
Dr Anne Laure Humbert - Reader in Gender and Diversity and Director of Centre for Diversity Policy Research and Practice, Oxford Brookes University
Dr Wanda Wyporska - Executive Director, The Equality Trust (Chair)
Event details
This webinar will take place on Tuesday 8th December from 10:00 to 11:30 via Zoom, and will feature presentations from plenary speakers followed by a panel Q&A.
Once you have completed the sign-up form, you will receive an email confirmation. The day before the event you will receive an email with sign-in details. This is a free, open event and we encourage people from different communities, political backgrounds, and walks of life to attend.
This event has been co-produced by The Equality Trust, Centre for Diversity Policy Research and Practice at Oxford Brookes University, the Royal College of Nursing and University of Surrey Business School.
Accessibility
Please contact Frankie, [email protected], if you have any accessibility needs (e.g. for an enlarged PDF agenda/joining instructions, subtitling) or for any further questions.
Transcript
Dr. Bailey: Hello everyone and thank you for joining us for the second AMA led discussion about the process that will eventually lead us to a vaccine for COVID-19. I'm Dr. Susan Bailey, president of the American Medical Association. The purpose of this call is to help physicians and the public have a better understanding of the vaccine development process, as well as allocation and distribution of a vaccine, or vaccines, when they become available. We appreciate all of you for taking the time to be a part of today's call and we kindly ask that if you're not a health care provider that you log off from the session at this time. Thanks.
Dr. Bailey: Now, if you weren't able to join us for last week’s call with Dr. Peter Marks, director of the Food and Drug Administration Center for Biologics Evaluation and Research, I encourage you to watch a video replay of our conversation, which can be found in our online COVID-19 resource center on our website. You can Google AMA COVID-19 resource center, or just type in ama-assn.org/COVID-19.
Dr. Bailey: Before I introduce our special guests for today's call, I want to take a moment on behalf of everyone at the AMA to send out my most sincere and heartfelt thank you to physicians everywhere who've responded so heroically to this pandemic. 2020 has tested us in ways that few could have imagined, but time and again, physicians, nurses and our entire health care community, have risen to the challenge of this moment. We still have a lot of work to do ahead of us to defeat COVID-19, but we know that the development of a safe and effective vaccine is a critical step toward a return to normalcy. The AMA has championed the widespread use of vaccines since the early 1960s, when the Sabin oral vaccine was developed to combat polio, and vaccines remain among the safest and most effective ways to prevent illness and protect public health.
Dr. Bailey: Of course, all of us are eagerly awaiting a vaccine for COVID-19, but we cannot rush the development of a vaccine at the expense of rigorous safety oversight. Rushing an unsafe or ineffective vaccine to market would compound the devastating effect of COVID-19. It was so important to hear from Dr. Marks at the FDA last week about the rigorous evidence-based safeguards in place during this accelerated vaccine development process.
Dr. Bailey: So today our guests will share their unique insights and perspectives into the planning and framework for successfully allocating and distributing a COVID-19 vaccine or vaccines. They'll discuss the role of the Advisory Committee on Immunization Practices, or ACIP, and providing recommendations for use of vaccines in the US civilian population. And they'll talk about the work of the CDC to ensure, once we have a safe and effective vaccine, that it's distributed across the country and that the appropriate data collection system is in place to track the vaccine supply, administration and monitor its safety.
Dr. Bailey: And they'll discuss the role physicians play in vaccine administration, and in promoting vaccine confidence. In a time of heightened concerns about this pandemic and with so much information, and disinformation, on vaccines in general, spreading online, the process we use to engage a skeptical public is critical to understand and discuss. Nobody understands this better than our two guests today. Dr. Nancy Messonnier is director of the National Center for Immunization and Respiratory Diseases, the NCIRD, at the Centers for Disease Control and Prevention. Dr. Messonnier has held a number of prominent leadership positions within the CDC, including serving as deputy director of NCIRD and leading the agency's meningitis and vaccine preventable disease branch from 2007 to 2012. An expert in global health and surveillance initiatives, Dr. Messonnier has spearheaded prevention and control for bacterial meningitis in the U.S. and in hotspots around the world.
Dr. Bailey: And we also are glad to have Dr. Amanda Cohn, the acting chief medical officer at NCIRD and executive secretary for the ACIP. Dr. Cohn, who's board certified in pediatrics, has led or played integral roles in multiple domestic and international meningococcal disease outbreak response efforts since joining the CDC in 2004.
Dr. Bailey: We're delighted to have both of these amazing physicians, these experienced infectious disease experts, with us today. After their remarks, we will have some questions that have been submitted in advance by the audience. So please join me in welcoming Dr. Nancy Messonnier and Dr. Amanda Cohn. Thank you. Dr. Messonnier, it's all yours.
Dr. Messonnier: Great. Thank you Dr. Bailey and thank you to the AMA for inviting us here today. Dr. Cohn and I, in our day jobs, work on a variety of vaccines, but we are now both deployed to the CDC emergency response to work specifically on planning for COVID vaccines. You can go on to the next slide. You all are true heroes in everything you've done this year. What I'm going to talk to you today is really the next step in those roles and I will start by saying that we understand your incredible importance in this planning around COVID vaccine delivery. The U.S. government has made a huge investment in developing and manufacturing safe and effective COVID vaccines, and yet, a vaccine that is safe and effective sitting on a shelf, is not helpful. For these vaccines to be useful, need to be used safely and effectively, and that's what we're going to talk to you about today.
our speaker Ms. ESRAA MOHAMMEDALHUSSIN ABDELHALIM ALI is giving her talk on the topic "Assessment of patients awareness regarding dietary preventive measures of irritable bowel syndrome in Ibn Sina hospital from February – April " on November 4th, 2020. Join the webinar to listen to her talk. Fill the below form to get the registration link with $4
Be the first to know and let us send you an email when International Webinar on Nursing and Emergency Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to International Webinar on Nursing and Emergency Medicine:
Want your business to be the top-listed Media Company?
